Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Carboplatin/Nab-Paclitaxel and Pembrolizumab for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02382406 is registered in ClinicalTrials.gov with Nisha Mohindra, MD as lead sponsor.

NCT NCT02382406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02382406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Carboplatin/Nab-Paclitaxel and Pembrolizumab for Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Nisha Mohindra, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
June 4, 2015
Completion date
April 14, 2022
Enrollment
46 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer